SLDB (Solid Biosciences Inc.) Quarterly EPS earnings growth

Graphic logo of Solid Biosciences Inc. (SLDB)

Solid Biosciences Inc. (SLDB) relies on robust scientific authority in the field of gene therapy. The quarterly EPS growth assessment on this GURU.Markets chart confirms this status, where 26.40 determines the latest valuation metric. The business is entirely non-cyclical and dependent on clinical trials. The company's strategy is based on developing breakthrough treatments for Duchenne muscular dystrophy.

Solid Biosciences (SLDB) Earnings per share growth in annualized terms for the last twelve months: for the period 07/04/2022 - 11/14/2026

Analytical breakdowns and data insights for company Solid Corp (SLDB)

- share price and expert price forecast:
Stock Price Solid Biosciences|SLDB - Price Target Chart
- business market valuation indicators:
Market Capitalization Solid Bio|SLDB - Company Buyout Price
- balance sheet net asset value indicators:
Net Assets per Single Share Solid Biosciences|SLDB - Total Stockholders' Equity|Market Value to Book Value Ratio solidbio.com|SLDB - Company Total Asset Base
- debt level and financial liquidity data:
Total Debt to Capital Solid Biosciences Inc.|SLDB - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Solid Biosciences Inc.|SLDB - Company Total Debt Obligations|Debts to Book Capitalization Solid Bio|SLDB - Long-Term Debt|Company Short-Term Debt Solid Biosciences|Quick Ratio solidbio.com
- earnings and market multiples details:
SLDB - Net Income|Projected Future Earnings Solid Biosciences Inc.|SLDB - Market Cap to Earnings|Future Price to Earnings Solid Bio|SLDB - Growth-Adjusted Market Cap to Net Income|Enterprise Value to EBITDA Ratio Solid Bio|SLDB - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Solid Biosciences|SLDB - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months solidbio.com|SLDB - Earnings per share growth this year|Earnings growth forecast for next year Solid Biosciences Inc.
- sales volume and revenue indicators:
SLDB - Company Sales|Company Future Sales Volume Solid Biosciences|SLDB - Price-to-Revenue Coefficient|Price-to-Projected Revenue Ratio Solid Bio
Analysis of all company metrics:Solid Biosciences - SLDB
Flagship merchandise of Solid Corp

Solid Biosciences Inc. (SLDB) focuses on the development of the gene therapy SGT-003, which defines the specifics of its cash flows. Earnings per share dynamics measure capital management efficiency and the business's resilience to market shocks. It is critical for investors to evaluate the overall profitability trend rather than one-off spikes. This allows for the monitoring of the cash burn rate during the clinical trial period. The trajectory of quarterly EPS growth serves as an indicator of the company's fundamental stability.

Analysis of competing companies

TEM: Quarterly EPS earnings growth|QGEN (Qiagen NV) - Year-over-year earnings per share growth for the last twelve months|IONS (Ionis Pharma) - Quarterly EPS earnings growth|Repligen Inc. (RGEN) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Avidity Biosciences (RNA)|CRSP - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months GeneDx WGS|Year-over-year net earnings per share change for the last twelve months Ultragenyx Pharmaceutical Inc. (RARE)|Beam Therapeutics Corp - Quarterly EPS earnings growth|Sarepta Corp (SRPT) - Year-over-year net earnings per share growth for the last 12 months|TWST: Quarterly EPS earnings growth|TXG - Year-over-year net earnings per share change for the last twelve months|NTLA (Intellia Therapeutics, Inc.) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Stoke Therapeutics Inc STOK|Year-over-year earnings per share growth for the last twelve months BioLife Corp (BLFS)|Wave Pharma - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth MAZE (Maze Therapeutics Inc)|SION - Year-over-year net earnings per share growth for the last 12 months|Prime Medicine - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Taysha Gene Therapies Inc|uniQure Corp (QURE) - Year-over-year earnings per share growth for the last twelve months|MGTX - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months RGNX|OCGN: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth PACB|Year-over-year net earnings per share change for the last twelve months Benitec Biopharma Inc|Year-over-year earnings per share growth for the last twelve months Design Pharma DSGN|RCKT: Year-over-year earnings per share growth for the last 12 months|4D Molecular Therapeutics - Quarterly EPS earnings growth|Lexeo Therapeutics (LXEO) - Year-over-year net earnings per share growth for the last 12 months|KRRO (korrobio.com) - Year-over-year net earnings per share growth for the last 12 months|EDIT - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Silence Therapeutics Inc.|ProQR Therapeutics NV (PRQR) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Codexis, Inc. (CDXS)|Year-over-year earnings per share growth for the last twelve months SGMO (sangamo.com)|Quarterly EPS earnings growth NAUT (Nautilus Bio)|MGX: Year-over-year earnings per share growth for the last 12 months|Precision BioSciences - Quarterly EPS earnings growth|GBIO: Year-over-year earnings per share growth for the last twelve months|BOLD: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months XCUR|Year-over-year earnings per share growth for the last twelve months Imunon Inc|Year-over-year earnings per share growth for the last 12 months PHIO (RXi Pharmaceuticals)|Quarterly EPS earnings growth MBIO|Quarterly EPS earnings growth transcodetherapeutics.com (RNAZ)|Year-over-year earnings per share growth for the last twelve months Bionano Genomics BNGO|Year-over-year net earnings per share change for the last twelve months adnas.com (APDN)|BLUE - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months ImmunoPrecise Antibodies|Omega (OMGA) - Year-over-year earnings per share growth for the last twelve months|OMIC (Singular Genomics Corp) - Year-over-year earnings per share growth for the last twelve months|RGLS (Regulus Therapeutics) - Quarterly EPS earnings growth|syros.com (SYRS) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth TBIO|TRACON Pharmaceuticals Inc. - Year-over-year earnings per share growth for the last 12 months|Unity Bio - Year-over-year net earnings per share growth for the last 12 months